Market revenue in 2023 | USD 159.6 million |
Market revenue in 2030 | USD 277.1 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.85% in 2023. Horizon Databook has segmented the Italy intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to OECD data, Italy has the largest geriatric population in the world, after Japan. In 2019, an estimated 23.1% of Italy’s total population was aged 65 years and above. In addition to the country’s increasing aged population, its youth population is decreasing.
These demographic trends impose numerous implications on the government and private sector players in the country. Over recent years, Italy has been facing a high burden of chronic diseases due to its aging population.
According to WHO, there is an increasing prevalence of cardiovascular diseases, cancer, musculoskeletal conditions (including lower back & neck pain), diabetes, and aging-related conditions such as Alzheimer’s disease. In 2018, 27% of the aging population was diagnosed with Alzheimer’s and 29% had hypertensive heart disease, according to the Institute of Health Metrics and Evaluation.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Italy intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account